tert-butyl (3R)-3-fluoro-4-oxopiperidine-1-carboxylate, 95.0%, 5g

EDTA sal dipotásica dihidrato, mínimo 99%, para síntesis, 250 g, envase de plástico.

4-(1H-tetrazol-1-yl)aniline hydrochloride, 95.0%, 2.5g

3-METHYL-5,6-DIHYDROBENZO[D]ISOXAZOL-7(4H)-ONE, 90.0%, 1g

N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N2-(2-((5-sulfonaphthalen-1-yl)amino)ethyl)-L-asparagine, 95%, 1g

rac-trans-2-Fluoro-cyclopropanecarboxylic acid, 95.0%, 250mg

3-(3-(Benzyloxy)pyridin-2-yl)prop-2-yn-1-ol, 98%, 50mg

4'-Fluoro-3'-trifluoromethyl-biphenyl-3-carboxylic acid, 95.0%, 10g

(4-Fluoro-3-trifluoromethylphenyl)acetic acid methyl ester, 99.0%, 1g

1H-Pyrrolo[2,3-b]pyridine-2-carboxamide, 95.0%, 250mg

6-Hydroxy-N,2-dimethylbenzofuran-3-carboxamide, 97%, 5g

trans-3-Amino-1-Boc-4-methoxypyrrolidine, 97.0%, 1g

Boc-L-Lysine, PEPTIPURE®, mínimo 98 %, para bioquímica, 5 g, envase de vidrio